Skip to main content

British tennis player Dan Evans banned one year for positive cocaine test

Dan Evans of Great Britain in action against Robin Haase of Netherlands during day three of the Mutua Madrid Open tennis at La Caja Magica on May 8, 2017 in Madrid, Spain.

Julian Finney/Getty Images

Davis Cup-winning tennis player Dan Evans will serve a one-year ban for testing positive for cocaine he said he kept in the pocket of a bag of toiletries.

The International Tennis Federation accepted on Tuesday that "inadvertent contamination" was responsible for the British player's positive test at the Barcelona Open in April.

Evans explained to an ITF panel he had used a small amount of cocaine when not competing four days before the test.

Story continues below advertisement

He then put the drug in a small travel bag where he also kept an approved medication he took during the Barcelona tournament.

The ITF accepted that Evans' fingers or medication became contaminated by cocaine residue.

The 27-year-old Evans, who was in Britain's Davis Cup-winning squad in 2015, is banned though April 23, 2018.

"Mr. Evans isgranted creditforhispromptadmission," the tennis governing body said, noting the "time and expensessavedbyreachinganagreedoutcomeratherthanhavingadisputed hearing."

He also forfeits 103,000 euros ($121,000) prize money and ranking points in events he played from late-April through June. His ranking peaked at No. 41 in March.

Report an error
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

If your comment doesn't appear immediately it has been sent to a member of our moderation team for review

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.